Network origin in Sumio Ito first degree
Entity | Entity type | Industry | |
---|---|---|---|
Meltin MMI KK
Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan.
3
| Holding Company | Medical Specialties | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sumio Ito via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Financial Services Agency | General Government | Corporate Officer/Principal | |
UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Hiroshima University | College/University | Doctorate Degree | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member | |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member | |
MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member |
Statistics
International
Japan | 4 |
United States | 4 |
Bermuda | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 7 |
Government | 2 |
Consumer Services | 2 |
Operational
Director/Board Member | 7 |
Corporate Officer/Principal | 2 |
Founder | 2 |
Independent Dir/Board Member | 1 |
Doctorate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Shigeyuki Nishinaka | 9 |
Tatsuya Seki | 1 |
Masahiro Kasuya | 1 |
- Stock Market
- Insiders
- Sumio Ito
- Company connections